# Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm

Study · id `cardio:ct-nct03581409` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03581409](<https://clinicaltrials.gov/study/NCT03581409>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT03581409

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 198 participants.

## Technical summary

Registry record NCT03581409. Randomized; no masking; primary purpose treatment. Start 2018-10-24 (actual); primary completion 2021-01-22 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 198 participants (enrolled count; ClinicalTrials.gov record NCT03581409, source copy `cardio:ctgov-nct03581409-2022-04-27`, retrieved 2026-11-18)
- Started: 2018-10-24 (actual) (ClinicalTrials.gov record NCT03581409, source copy `cardio:ctgov-nct03581409-2022-04-27`, retrieved 2026-11-18)
- Primary completion: 2021-01-22 (actual) (ClinicalTrials.gov record NCT03581409, source copy `cardio:ctgov-nct03581409-2022-04-27`, retrieved 2026-11-18)
- Completion: 2021-01-22 (actual) (ClinicalTrials.gov record NCT03581409, source copy `cardio:ctgov-nct03581409-2022-04-27`, retrieved 2026-11-18)
- Countries: South Korea (ClinicalTrials.gov record NCT03581409, source copy `cardio:ctgov-nct03581409-2022-04-27`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03581409-2022-04-27`, retrieved 2026-11-18)

## The registry's words

- Brief title: Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm
- Condition: Aneurysm, Cerebral
- Condition: Endovascular Procedures
- Intervention (Drug): Aspirin
- Intervention (Drug): Prasugrel
- Intervention (Drug): Clopidogrel
- Intervention (Drug): Cilostazol
- Lead sponsor: Seoul National University Hospital
- Lead sponsor class: OTHER
- Collaborator: Seoul National University Bundang Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry intervention name matches this record: Prasugrel (`cardio:prasugrel`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry lists this organization as the lead sponsor: Seoul National University Hospital (`cardio:org-seoul-national-university-hospital`)
- Registry lists this organization as a collaborator: Seoul National University Bundang Hospital (`cardio:org-seoul-national-university-bundang-hospital`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of Triple Antiplatelet (Aspirin, Clopidogrel, and Cilostazol) and Modified Dual Antiplatelet (Aspirin and Low-Dose Prasugrel) Therapy in Patients With High On-Treatment Platelet Reactivity Undergoing Stent-Assisted Coil Embolization for an Unruptured Intracranial Aneurysm: A Prospective Randomized Clinical Trial (`cardio:pubmed-41070954`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: bf1816143f5ddfbc273b57570a0fa18dd243147620a2d906b90ee9dcec3e1ae5
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
